All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Neurofilament Heavy Polypeptide | NCIT_C88040 | [Neurofilament heavy polypeptide (1026 aa, ~112 kDa) is encoded by the human NEFH gene. This protein plays a role in both the establishment and maintenance of axonal and dendritic structures.] |
| NEFL Gene | NCIT_C88041 | [This gene is involved in the structure of neuronal processes.] |
| NEFL wt Allele | NCIT_C88042 | [Human NEFL wild-type allele is located in the vicinity of 8p21 and is approximately 6 kb in length. This allele, which encodes neurofilament light polypeptide protein, plays a role in both the establishment and maintenance of axonal and dendritic structures. Mutation of the gene is associated with Charcot-Marie-Tooth disease types 1F and 2E.] |
| Neurofilament Light Polypeptide | NCIT_C88043 | [Neurofilament light polypeptide (543 aa, ~62 kDa) is encoded by the human NEFL gene. This protein is involved in the modulation of neuronal structure.] |
| Metastatic Malignant Neoplasm in the Small Intestine | NCIT_C7524 | [A malignant neoplasm that has spread to the small intestine from another anatomic site.] |
| Malignant Renal Pelvis Neoplasm | NCIT_C7525 | [A primary or metastatic malignant neoplasm that affects the renal pelvis.] |
| Renal Pelvis Neoplasm | NCIT_C8404 | [A neoplasm involving the renal pelvis.] |
| Papillary Intralymphatic Angioendothelioma | NCIT_C7526 | [An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of lymphatic-like vascular channels and papillary endothelial proliferation.] |
| Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm | NCIT_C45474 | [A borderline blood vessel neoplasm that may metastasize on rare occasions.] |
| Hemangioendothelioma | NCIT_C3084 | [A vascular proliferation characterized by the presence of prominent endothelial cells and the formation of vascular channels. Hemangioendotheliomas may display borderline or low grade characteristics.] |
| Pulmonary Sulcus Neoplasm | NCIT_C27710 | [A neoplasm originating from the apical lung. Most superior sulcus neoplasms are bronchogenic carcinomas. This tumor may be associated with Pancoast syndrome. It is also known as Pancoast tumor.] |
| CDISC SEND Body System Terminology | NCIT_C88026 | [The terminology that includes concepts relevant to the Clinical Data Interchange Standards Consortium (CDISC) Standard for the Exchange of Non-clinical Data (SEND) body systems.] |
| Stage II Renal Pelvis and Ureter Cancer AJCC v7 | NCIT_C7520 | [Stage II includes: T2, N0, M0. T2: Tumor invades the muscularis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)] |
| Stage 0 Digestive System Neuroendocrine Tumor AJCC v7 | NCIT_C88027 | [Stage 0 includes: Tis, N0, M0. Tis (applies only to stomach): Carcinoma in situ/dysplasia (tumor size less than 0.5 mm), confined to mucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)] |
| Digestive System Neuroendocrine Tumor by AJCC v7 Stage | NCIT_C135129 | [A term that refers to the staging of a digestive system neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system.] |
| Stage III Renal Pelvis and Ureter Cancer AJCC v7 | NCIT_C7521 | [Stage III includes: T3, N0, M0. T3: For renal pelvis only: tumor invades beyond muscularis into peripelvic fat or the renal parenchyma. For ureter only: tumor invades beyond muscularis into periureteric fat. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)] |
| Stage I Digestive System Neuroendocrine Tumor AJCC v7 | NCIT_C88028 | [Stage I includes: T1, N0, M0. T1: Stomach: tumor invades lamina propria or submucosa and is 1 cm or less in size; duodenum /jejunum/ileum: tumor invades lamina propria or submucosa and is 1 cm or less in size; ampulla: tumor 1 cm or less; colon or rectum: tumor invades lamina propria or submucosa and is 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)] |
| Stage IV Renal Pelvis and Ureter Cancer AJCC v7 | NCIT_C7522 | [Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, N2, M0); (Any T, N3, M0); (Any T, Any N, M1). T4: Tumor invades adjacent organs, or through the kidney into the perinephric fat. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension. N3: Metastasis in a lymph node, more than 5 cm in greatest dimension. M0: No distant metastasis. N1: Distant metastasis. (AJCC 7th ed.)] |
| Stage IIA Digestive System Neuroendocrine Tumor AJCC v7 | NCIT_C88029 | [Stage IIA includes: T2, N0, M0. T2: Stomach/ duodenum /jejunum/ileum: tumor invades muscularis propria or is more than 1 cm in size; ampulla: tumor is more than 1 cm in size; colon or rectum: tumor invades muscularis propria or is more than 2 cm in size with invasion of lamina propria or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)] |
| Small Intestinal Neoplasm | NCIT_C4432 | [A benign or malignant neoplasm that affects the small intestine. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma.] |